Company Presentation • 13 Nov 2024 21:00
Company Presentation • 27 Jun 2024 20:00
Company Presentation • 28 Mar 2024 20:00
Company Presentation • 28 Nov 2023 06:00
Company Presentation • 17 May 2023 04:00
ENTITY
X4 Pharmaceuticals (XFOR US)
X4 Pharmaceuticals (XFOR US)
5
Analysis
Health Care • United States
X4 Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company specializes in developing novel therapeutics designed to improve immune cell trafficking to treat rare diseases including primary immunodeficiencies and cancer. X4's oral small molecule drug candidates antagonize the CXCR4 pathway which plays a central role in immune surveillance.
more
x